A Randomized, Open-Label Study of the Long-Term Effectiveness of Three Initial Highly Active Antiretroviral Therapy (HAART) Strategies in HAART-Niave, HIV-Infected Persons
Latest Information Update: 18 Sep 2021
At a glance
- Drugs HIV protease inhibitors; Non-nucleoside reverse transcriptase inhibitors; Nucleoside reverse transcriptase inhibitors
- Indications HIV infections; HIV-1 infections
- Focus Therapeutic Use
- Acronyms FIRST
- 17 Apr 2014 Biomarkers information updated
- 13 Feb 2013 New trial record